Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from RD

Cognition Therapeutics Begins Mid-Stage Study Of Neurological Disorder Candidate

Cognition Therapeutics (NASDAQ: CGTX) dosed first patient in the SHIMMER study of lead drug CT1812, an experimental, orally delivered small molecule therapeutic intended to address the underlying biology of dementia with Lewy bodies (DLB).

Benzinga

Abbott Laboratories vs. Edwards Lifesciences: Which Medical Device Stock is a Better Investment?

The growing prevalence of chronic diseases, an increasing elderly population, and rapid adoption of advanced medical technologies are driving the growth of the medical device industry. The industry is expected to witness solid growth over the long term, to the benefit of the stocks of medical device companies Abbott (ABT)…

StockNews.com

Lessons learned from an analyst’s journey into COVID-Zero China

Wenting Shen usually travels to China annually as part of her job as an analyst and portfolio manager at investment company Harding Loevner, but the country’s strict “COVID Zero” policies and this year’s Winter Olympics in Beijing made it almost impossible to book a flight.

Tribune News Service

From analysis to the latest developments in health,
read the most diverse news in one place.

After Rising to Fame as Hot Audio Social App, Yalla Finds New Role Model in Facebook

Key Takeaways: Yalla said its first-quarter revenue rose 6.9% to a record $72.3 million, as strong gains for its game services offset a first-time decline for its core voice business Company is launching a wide array of new initiatives, including an instant messaging app and its first-ever hardcore game, in…

Benzinga

Edinburgh local looking for love on ITV's Romeo and Duet dating show shares all

Romeo and Duet contestant Jamie, from Edinburgh, is looking to find love "with a pinch of salt" on former Strictly star Oti Mabuse's ITV dating show, airing on Saturday nights.

Edinburgh Live

Republicans split on adding semiconductor tax breaks to competition bill

An effort to add bipartisan tax incentives for U.S. semiconductor manufacturing to a House bill is running into GOP divisions.

Roll Call

Caladrius Biosciences To Merge With Privately-Held Cend Therapeutics

Caladrius Biosciences Inc (NASDAQ:CLBS) and privately-held Cend Therapeutics Inc have agreed to merge in an all-stock approximate "merger of equals" transaction approved by the Boards of Directors of each company. The transaction values each company at $90 million, which for Caladrius represents a 136% premium to its market cap on April 26. Following closing, the…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

GT300-rules cars slowed for Okayama SUPER GT opener

SUPER GT's GT300-rules cars have been slowed in relation to their FIA GT3 rivals according to the Balance of Performance for next weekend's Okayama season opener.

Motorsport

Yes, the Stock Market Just Went Into Free Fall—It’s Not the Metric You Should Worry About.

The Dow dropped a record 1,175 points yesterday. Don’t worry. A better gauge of the future is going up.

Fortune

1 2 3 4

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations